294 related articles for article (PubMed ID: 15214797)
1. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
[TBL] [Abstract][Full Text] [Related]
3. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents.
Reddy MV; Mallireddigari MR; Cosenza SC; Pallela VR; Iqbal NM; Robell KA; Kang AD; Reddy EP
J Med Chem; 2008 Jan; 51(1):86-100. PubMed ID: 18088089
[TBL] [Abstract][Full Text] [Related]
6. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
[TBL] [Abstract][Full Text] [Related]
7. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
Georg GI; Ali SM; Stella VJ; Waugh WN; Himes RH
Bioorg Med Chem Lett; 1998 Aug; 8(15):1959-62. PubMed ID: 9873466
[TBL] [Abstract][Full Text] [Related]
8. Effects of altering the electronics of 2-methoxyestradiol on cell proliferation, on cytotoxicity in human cancer cell cultures, and on tubulin polymerization.
Edsall AB; Mohanakrishnan AK; Yang D; Fanwick PE; Hamel E; Hanson AD; Agoston GE; Cushman M
J Med Chem; 2004 Oct; 47(21):5126-39. PubMed ID: 15456256
[TBL] [Abstract][Full Text] [Related]
9. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Prinz H; Ishii Y; Hirano T; Stoiber T; Camacho Gomez JA; Schmidt P; Düssmann H; Burger AM; Prehn JH; Günther EG; Unger E; Umezawa K
J Med Chem; 2003 Jul; 46(15):3382-94. PubMed ID: 12852768
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship studies of targeting ligands against breast cancer cells.
Yao N; Xiao W; Meza L; Tseng H; Chuck M; Lam KS
J Med Chem; 2009 Nov; 52(21):6744-51. PubMed ID: 19835381
[TBL] [Abstract][Full Text] [Related]
11. Total synthesis and biological evaluation of potent analogues of dictyostatin: modification of the C2-C6 dienoate region.
Paterson I; Gardner NM; Guzmán E; Wright AE
Bioorg Med Chem Lett; 2008 Dec; 18(23):6268-72. PubMed ID: 18951787
[TBL] [Abstract][Full Text] [Related]
12. Cryptophycin affinity labels: synthesis and biological activity of a benzophenone analogue of cryptophycin-24.
Vidya R; Eggen M; Georg GI; Himes RH
Bioorg Med Chem Lett; 2003 Feb; 13(4):757-60. PubMed ID: 12639575
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
[TBL] [Abstract][Full Text] [Related]
14. Scaffold targeting drug-resistant colon cancers.
Otrubova K; McGuire KL; McAlpine SR
J Med Chem; 2007 May; 50(9):1999-2002. PubMed ID: 17411027
[TBL] [Abstract][Full Text] [Related]
15. N-benzoylated phenoxazines and phenothiazines: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Prinz H; Chamasmani B; Vogel K; Böhm KJ; Aicher B; Gerlach M; Günther EG; Amon P; Ivanov I; Müller K
J Med Chem; 2011 Jun; 54(12):4247-63. PubMed ID: 21563750
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxicity studies of new cryptophycin analogues.
Liu WL; Zhang JC; Jiang FQ; Fu L
Arch Pharm (Weinheim); 2009 Oct; 342(10):577-83. PubMed ID: 19714674
[TBL] [Abstract][Full Text] [Related]
18. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles.
Davis MR; Styers TJ; Rodriguez RA; Pan PS; Vasko RC; McAlpine SR
Org Lett; 2008 Jan; 10(2):177-80. PubMed ID: 18095697
[TBL] [Abstract][Full Text] [Related]
20. First generation design, synthesis, and evaluation of azepine-based cryptophycin analogues.
Smith AB; Cho YS; Zawacki LE; Hirschmann R; Pettit GR
Org Lett; 2001 Dec; 3(25):4063-6. PubMed ID: 11735585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
